AGM - Trade Update

Sopheon PLC 25 June 2004 Embargoed Release: 07:00hrs 25th June 2004 SOPHEON PLC AGM: Trading Update, Balance Sheet Improved At the Annual General Meeting of Sopheon plc ('Sopheon') to be held later today, the board will give shareholders an update on trading, as well as actions being taken to further strengthen its balance sheet. This will include the following statement: 'I am pleased to report that Sopheon continues to make significant progress towards meeting its operational objectives. Fourteen transactions were closed in the first quarter, comprising 7 proof-of-concept and consulting assignments, 4 new license sales and 3 extension orders to existing implementations. There have been further successes in all categories in the second quarter. Taking revenue to date, recurring revenue streams, and new orders including contracts conditional on acceptance decisions, visibility of 2004 revenues now exceeds 90% of the total revenues recorded in 2003 for the continuing software business. We are actively pursuing signature on several additional contracts for closure by the end of June. Coming up to the mid-year point, this has already been a year of substantial strategic development, including our advancement to the top tier of Microsoft's partner network through qualification for 'Gold' status, initiation of an application hosting service for Accolade customers, and winning our first customer in the financial services sector. Overall, we continue to see high rates of adoption of Accolade within our installed base, where our largest single client implementation is operating with 1500 seats. In addition, we have signed our first contracts extending the use of Accolade to automate and improve business processes beyond the product development area. Further details of our first-half performance will be provided in our 2004 interim statement, expected to be issued around the end of August. As indicated in our Annual Report, the board has been considering a range of options to propose to the holders of the Company's £2.5m convertible loan stock in the event that some or all of it remains unconverted at the time of maturity in June 2005. Accordingly, proposals are being put to the holders of the of the loan stock that would defer maturity until December 2005, reconstitute the instrument such that it will automatically convert into equity rather than be repayable upon maturity, and eliminate the 6% annual interest coupon. These modifications would also result in the instrument being classified as equity rather than debt in the Company's balance sheet. We are pleased to report that we have received agreement from holders of a majority of the convertible loan stock to these proposals. The terms being put to the loan stock holders also include an up-front 7% payment to compensate for the loss of interest and repayment rights. Partly to offset this cost, but also to underline the renewed strength of Sopheon's balance sheet going forward, the Company has today placed a total of 4,651,163 ordinary shares at 21.5p per share to raise £1,000,000 before expenses of working capital for the Company. Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 30 June 2004. The combined effect of this placing and the reclassification of the loan note is expected to improve Sopheon's balance sheet position by over £3m. With this, combined with evidence of an improving outlook for revenues, the mood in the business is increasingly confident as we move further towards our objective of becoming a leading international supplier of software and services that improve the financial return on innovation and product development investments.' For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Barbara Jansen Citigate First Financial Tel : + 31 (0) 205 754 010 About Sopheon Sopheon (LSE: SPE) is an international provider of software and services. The Sopheon Accolade product development system automates gate- or phase-based product development processes and provides strategic decision support that allows companies to improve innovation, cut product development spending waste and shorten time-to-market. Sopheon's Monitor software operates as a 'reading robot' that automatically reviews, filters, analyzes and pushes relevant content to healthcare and engineering professionals to enable effective compliance with protocols, standards and regulations. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com This information is provided by RNS The company news service from the London Stock Exchange AE

Companies

Sopheon (SPE)
UK 100

Latest directors dealings